BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 489316)

  • 1. The influence of DTPA on the metabolism of inhaled 239PuF4 in beagles.
    McDonald KE; Dilley JV; Sanders CL; Mahaffey JA
    Health Phys; 1979 May; 36(5):632-5. PubMed ID: 489316
    [No Abstract]   [Full Text] [Related]  

  • 2. Pu and Am decorporation in beagles: effects of magnitude of initial Ca-DTPA injection upon chelation efficacy.
    Lloyd RD; Jones CW; Taylor GN; Mays CW; Atherton DR
    Radiat Res; 1979 Sep; 79(3):630-34. PubMed ID: 113846
    [No Abstract]   [Full Text] [Related]  

  • 3. The efficacy of Zn DTPA for the decorporation of 238Pu-TBP injected into the lungs of hamsters.
    Stradling GN; Stather JW; Ham SE; Sumner SA; Cooper JR
    Health Phys; 1983 Jun; 44(6):645-9. PubMed ID: 6853187
    [No Abstract]   [Full Text] [Related]  

  • 4. Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA.
    Stradling GN; Stather JW; Sumner SA; Strong JC; Lennox AM; Ham SE
    Health Phys; 1984 Apr; 46(4):919-24. PubMed ID: 6706599
    [No Abstract]   [Full Text] [Related]  

  • 5. Removal of polymeric plutonium from dogs with DTPA and glucan.
    Rosenthal MW; Lindenbaum A; Baxter DW; Kalesperis GS; Moretti ES; Russell JJ
    Radiat Res; 1975 Aug; 63(2):253-61. PubMed ID: 1096228
    [No Abstract]   [Full Text] [Related]  

  • 6. Removal of inhaled 239PuF4 in beagles. BNWL-714.
    Dilley JV; McDonald KE
    BNWL Rep; 1968 May; ():6.11. PubMed ID: 5306301
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of DTPA on inhaled 239PuF4 in beagles. BNWL-1050.
    Dilley JV
    BNWL Rep; 1970 Jan; ():5.14+. PubMed ID: 5311294
    [No Abstract]   [Full Text] [Related]  

  • 8. Plutonium ( 239 Pu) toxicity diagnosis and therapy.
    Norwood WD
    J Occup Med; 1972 Jan; 14(1):37-44. PubMed ID: 5058618
    [No Abstract]   [Full Text] [Related]  

  • 9. A mathematical model for estimation of plutonium in the human body from urine data influenced by DTPA therapy.
    Hall RM; Poda GA; Fleming RR; Smith JA
    Health Phys; 1978 May; 34(5):419-31. PubMed ID: 711453
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracellular plutonium: removal by liposome-encapsulated chelating agent.
    Rahman YE; Rosenthal MW; Cerny EA
    Science; 1973 Apr; 180(4083):300-2. PubMed ID: 4633691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plutonium: biomedical research.
    Bair WJ; Thompson RC
    Science; 1974 Feb; 183(4126):715-22. PubMed ID: 4595239
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of plutonium introduced as Tri-N-Butylphosphate complex in the rat and removal attempts by DTPA.
    Metivier H; Masse R; Lafuma J
    Health Phys; 1983 Jun; 44(6):623-34. PubMed ID: 6853185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plutonium retention, excretion, and distribution in juvenile beagles soon after injection.
    Lloyd RD; McFarland SS; Atherton DR; Mays CW
    Radiat Res; 1978 Sep; 75(3):633-41. PubMed ID: 103128
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of Ca-DTPA as a treatment for plutonium inhaled in mixed oxide aerosols of plutonium and sodium.
    Stather JW; Rodwell P
    Health Phys; 1980 Nov; 39(5):801-5. PubMed ID: 7204032
    [No Abstract]   [Full Text] [Related]  

  • 15. Decorporation of Pu and Am from beagles with delayed daily injections of 3,4,3-LICAM(C) or Zn-DTPA.
    Mays CW; Lloyd RD; Jones CW; Bruenger FW; Taylor GN; Durbin PW; White D; Raymond KN
    Health Phys; 1986 Apr; 50(4):530-4. PubMed ID: 3754241
    [No Abstract]   [Full Text] [Related]  

  • 16. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental studies of the use of DTPA and other agents to limit the systemic burden of plutonium after wound contamination.
    Harrison JD; David AJ
    Radiat Res; 1979 Mar; 77(3):534-46. PubMed ID: 441257
    [No Abstract]   [Full Text] [Related]  

  • 18. The in vivo solubility of plutonium-239 dioxide in the rat lung.
    Smith H; Stradling GN; Loveless BW; Ham GJ
    Health Phys; 1977 Dec; 33(6):539-51. PubMed ID: 604297
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of DTPA therapy on long-term effects of retained monomeric plutonium: comparison with polymeric plutonium.
    Osenthal MW; Lindenbaum A
    Radiat Res; 1967 Jul; 31(3):506-21. PubMed ID: 6027890
    [No Abstract]   [Full Text] [Related]  

  • 20. Decorporation of monomeric plutonium from the dog by glucan and-or DTPA.
    Baxter DW; Rosenthal MW; Lindenbaum A
    Radiat Res; 1973 Jul; 55(1):144-52. PubMed ID: 4716888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.